These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8626790)

  • 1. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.
    Hoeg JM; Vaisman BL; Demosky SJ; Meyn SM; Talley GD; Hoyt RF; Feldman S; Bérard AM; Sakai N; Wood D; Brousseau ME; Marcovina S; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1996 Feb; 271(8):4396-402. PubMed ID: 8626790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.
    Brousseau ME; Santamarina-Fojo S; Zech LA; Bérard AM; Vaisman BL; Meyn SM; Powell D; Brewer HB; Hoeg JM
    J Clin Invest; 1996 Apr; 97(8):1844-51. PubMed ID: 8621767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.
    Brousseau ME; Santamarina-Fojo S; Vaisman BL; Applebaum-Bowden D; Bérard AM; Talley GD; Brewer HB; Hoeg JM
    J Lipid Res; 1997 Dec; 38(12):2537-47. PubMed ID: 9458277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
    Furbee JW; Parks JS
    Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
    Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
    J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
    Furbee JW; Sawyer JK; Parks JS
    J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia.
    Kurasawa T; Yokoyama S; Miyake Y; Yamamura T; Yamamoto A
    J Biochem; 1985 Dec; 98(6):1499-508. PubMed ID: 3867663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of plasma lecithin:cholesterol acyltransferase in man. III. Role of high density lipoprotein cholesteryl esters in the activating effect of a high-fat test meal.
    Rose HG; Juliano J
    J Lipid Res; 1979 Mar; 20(3):399-407. PubMed ID: 221605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein expressed in lecithin cholesterol acyltransferase-deficient mice.
    Wu CA; Tsujita M; Okumura-Noji K; Usui S; Kakuuchi H; Okazaki M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1347-53. PubMed ID: 12171799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
    Nanjee MN; Cooke CJ; Olszewski WL; Miller NE
    J Lipid Res; 2000 Aug; 41(8):1317-27. PubMed ID: 10946020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.